Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519930 · ClinicalTrials.gov registry record
Pancreatic Cancer Early Detection Registry
A clinical trial, sponsored by Hoag Memorial Hospital Presbyterian.
- Completed
- Registry status
- 326
- Enrollment target
NCT05519930: Completed study, sponsored by Hoag Memorial Hospital Presbyterian.
NCT05519930 is a clinical trial that has completed, run by Hoag Memorial Hospital Presbyterian. The registered enrollment target is 326 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05519930 has completed, sponsored by Hoag Memorial Hospital Presbyterian.
- COMPLETED
- Registry status
- 326 participants
- Enrollment target
Study Summary
Identify individuals who are at moderate and high risk or predisposed to developing pancreatic cancer with a familial history in which data collected from this study will be used to identify clinical factors associated with early detection of pancreatic cancer.
Primary Outcome
Imaging includes CT/MRI abdomen with and without contrast using the pancreatic protocol, screening for solid pancreatic lesions, atypical cysts and IPMN, pancreatic duct dilatation, pancreas divisum.
Interventions
- OTHER hereditary high risk pancreatic cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2016-10-18 |
| Est. Completion | 2023-07-27 |
What the finished NCT05519930 record still lists
NCT05519930 is an observational study that tracks outcomes without assigning an intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which hereditary high risk pancreatic cancer is the first listed.
NCT05519930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05519930 about?
NCT05519930 is a clinical study titled "Pancreatic Cancer Early Detection Registry". Identify individuals who are at moderate and high risk or predisposed to developing pancreatic cancer with a familial history in which data collected from this study will be used to identify clinical factors associated with early detection of pancreatic cancer.
What is the current status of trial NCT05519930?
This trial is currently completed. The enrollment target is 326 participants. The study started on 2016-10-18. Estimated completion is 2023-07-27.
What interventions are being tested in trial NCT05519930?
The interventions under investigation include: hereditary high risk pancreatic cancer (OTHER).
Who is sponsoring clinical trial NCT05519930?
This trial is sponsored by Hoag Memorial Hospital Presbyterian, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06410144 · 326 participants · NA
Chronic Kidney Disease-Education (CKD-EDU)
- NCT06586619 · 326 participants · NA
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- NCT07040566 · 326 participants · Phase 2
A Trial of Varenicline for E-cigarette Cessation
- NCT07165860 · 326 participants · NA
Clinical Trial to Reduce Perinatal Intimate Partner Violence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI